Low Number of H-2Dd-Negative Haematopoietic Cells in Mixed Bone Marrow Chimeras Convey In Vivo Tolerance to H-2Dd-Negative Cells but Fail to Prevent Resistance to H-2Dd-Negative Leukaemia

Scandinavian Journal of Immunology

Volumn 59, Issue 1, 2004, Pages 71-78

  Johansson, M H ^a   Hoglund P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; H2 ANTIGEN; HISTOCOMPATIBILITY ANTIGEN H 2D(B); HISTOCOMPATIBILITY ANTIGEN H-2D(B);

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CELL ACTIVITY; CHIMERA; CONTROLLED STUDY; HEMATOPOIETIC CELL; IN VIVO STUDY; LEUKEMIA; LYMPHOMA CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; GENETICS; GRAFT REJECTION; HEMATOPOIETIC STEM CELL; HISTOCOMPATIBILITY; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; BONE MARROW TRANSPLANTATION; GRAFT REJECTION; H-2 ANTIGENS; HEMATOPOIETIC STEM CELLS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; LEUKEMIA; MICE; MICE, TRANSGENIC; TRANSPLANTATION CHIMERA;

EID: 0442291928     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0300-9475.2004.01363.x     Document Type: Article

References (29)

1. Lanier LL. NK cell receptors. Annu Rev Immunol 1998;16:359-93.
2. Takei F, Brennan J, Mager DL. The Ly-49 family: genes, proteins and recognition of class I MHC. Immunol Rev 1997;155:67-77.
3. Vance RE, Kraft JR, Altman JD, Jensen PE, Raulet DH. Mouse CD94/NKG2A is a natural killer cell receptor for the nonclassical major histocompatibility complex (MHC) class I molecule Qa-1 (b). J Exp Med 1998;188:1841-8.
4. Moretta A, Biassoni R, Bottino C et al. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol Rev 1997;155:105-17.
5. McQueen KL, Parham P. Variable receptors controlling activation and inhibition of NK cells. Curr Opin Immunol 2002;14:615-21.
6. Ljunggren HG, Kärre K. In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 1990;11:237-44.
7. Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat Immunol 2000;1:119-26.
8. Cerwenka A, Lanier LL. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 2001;181:158-69.
9. Bennett M. Biology and genetics of hybrid resistance. Adv Immunol 1987;41:333-445.
10. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989;47:187-376.
11. Höglund P, Sundbäck J, Olsson-Alheim MY et al. Host MHC class I gene control of NK-cell specificity in the mouse. Immunol Rev 1997;155:11-28.
12. Ruggeri L, Capanni M, Casucci M et al. Role of natutal killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation. Blood 1999;94:333-9.
13. Zijlstra M, Auchincloss H Jr, Loring JM, Chase CM, Russell PS, Jaenisch R. Skin graft rejection by beta 2-microglobulin-deficient mice. J Exp Med 1992;175:885-93.
14. Wu MF, Raulet DH. Class I-deficient hemopoietic cells and non-hemopoietic cells dominantly induce unresponsiveness of natural killer cells to class I-deficient bone marrow cell grafts. J Immunol 1997;158:1628-33.
15. Kung SK, Miller RG. Mouse natural killer subsets defined by their target specificity and their ability to be separately rendered unresponsive in vivo. J Immunol 1997;158:2616-26.
16. Ruggeri L, Capanni M, Urbani E et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097-100.
17. Johansson MH, Bieberich C, Jay G, Kärre K, Höglund P. Natural killer cell tolerance in mice with mosaic expression of major histocompatibility complex class I transgene. J Exp Med 1997;186:353-64.
18. Ioannidis V, Zimmer J, Beermann F, Held W. Cre recombinase-mediated inactivation of H-2Dd transgene expression: evidence for partial missing self-recognition by Ly49A NK cells. J Immunol 2001;167:6256-62.
19. Bieberich C, Scangos G, Tanaka K, Jay G. Regulated expression of a murine class I gene in transgenic mice. Mol Cell Biol 1986;6:1339-42.
20. + T cells. Science 1990;248:1227-30.
21. + T cells and natural killer cells. Proc Natl Acad Sci USA 1998;95:12492-7.
22. Koo GC, Dumont FJ, Tutt M, Hackett J, Kumar V. The NK-1.1(-) mouse: a model to study differentiation of murine NK cells. J Immunol 1986;137:3742-7.
23. Gays F, Unnikrishnan M, Shrestha S et al. The mouse tumor cell lines EL4 and RMA display mosaic expression of NK-related and certain other surface molecules and appear to have a common origin. J Immunol 2000;164:5094-102.
24. Sentman CL, Olsson MY, Salcedo M, Höglund P, Lendahl U, Kärre K. H-2 allele-specific protection from NK cell lysis in vitro for lymphoblasts but not tumor targets. Protection mediated by alpha 1/alpha 2 domains. J Immunol 1994;153:5482-90.
25. Höglund P, Ljunggren HG, Öhlén C et al. Natural resistance against lymphoma grafts conveyed by H-2Dd transgene to C57BL mice. J Exp Med 1988;168:1469-74.
26. Shearer GM, Polisson RP. Mutual recognition of parental and F1 lymphocytes. Selective abrogation of cytotoxic potential of F1 lymphocytes by parental lymphocytes. J Exp Med 1980;151:20-31.
27. Ishikawa H, Kubota E, Wilkinson NM, Saito K. Modulation of F1 cytotoxic potentials by GvHR: suppression of cytotoxic T cell responses of F1 mice correlates with F1 inability to resist the proliferation of GvHR-inducing parental T lymphocytes. J Immunol 1982;129:1181-8.
28. Hakim FT, Shearer GM. Abrogation of hybrid resistance to bone marrow engraftment by graft-vs-host-induced immune deficiency. J Immunol 1986;137:3109-16.
29. Glas R, Franksson L, Une C et al. Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses. J Exp Med 2000;191:129-38.